PCSK9 and atherosclerosis: Variants in the PCSK9 gene, known to increase LDL levels, have been linked to an increased risk of subclinical atherosclerosis [155], with elevated plasma PCSK9 levels directly correlated with LDL levels in patients undergoing PD [168].